GMED is an educational platform created by Gilead Sciences.
GMED is not meant to give medical or clinical advice. If you have medical questions related to any Gilead's product or therapeutic area, please email: askGileadME@gilead.com
Reporting suspected adverse reactions of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable. Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via firstname.lastname@example.org
For technical questions, please contact GMED.email@example.com
This is a service provided for healthcare professionals, for educational purposes.
Date of preparation: December 2020. Approval Code: ME-GIL-2020-11-0003